| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Fortress Biotech, Inc. | 12% | $1,708,057 | 6,569,450 | Fortress Biotech, Inc. | 31 Dec 2024 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$826,455 | 0 | |
| 2024 Q4 | 4,670,658 | $826,515 | +$649,537 | $0.1770 | 28 |
| 2024 Q3 | 879,309 | $207,208 | -$5,892 | $0.2353 | 24 |
| 2024 Q2 | 786,143 | $372,645 | -$150,757 | $0.4730 | 27 |
| 2024 Q1 | 743,608 | $774,083 | -$344,102 | $1.04 | 28 |
| 2023 Q4 | 1,033,145 | $1,396,080 | +$579,173 | $1.35 | 25 |
| 2023 Q3 | 592,470 | $1,222,173 | -$391,889 | $2.07 | 24 |
| 2023 Q2 | 634,756 | $3,943,412 | +$3,943,412 | $6.21 | 28 |